SRTTY vs ACT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SRTTY · ZOZO INC UNSP ADR EACH REP 1 ORD SHS$7.40 ▼ 1.73%
ACT · Enact Holdings$44.18 ▼ 0.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SRTTY -12.5%
- ACT +17.2%
Head to head
| Metric | SRTTY | ACT |
|---|---|---|
| Price | $7.40 | $44.18 |
| Change today | ▼ 1.73% | ▼ 0.02% |
| Market cap | $5.94B | $5.94B |
| Return, 3 months | +7.6% | -11.1% |
| Return, year to date | -12.2% | +13.2% |
| Return, 1 year | -15.4% | +16.6% |
| P/E (TTM) | 21.1 | 9.2 |
| P/B | 11.0 | 1.1 |
| P/E percentile vs own 5y | – | 91st |
| Dividend yield | 1.68% | 2.04% |
| Revenue growth (YoY, latest qtr) | – | +0.5% |
| Net profit growth (YoY) | – | -2.8% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 54.1% |
| Return on equity | – | 12.9% |
| Analyst target vs. price | – | +4.1% |
| Analyst buy share | – | 0% |
| RSI (14) | 53 | 35 |
| 30-day volatility | 39.3% | 22.8% |
| Max drawdown, 1 year | -34.8% | -13.6% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ACT is the largest of the group by market value.
- ACT has returned the most over the past year.
- ACT carries the lowest trailing P/E.
- ACT pays the highest dividend yield.
- ACT has been the calmest stock over the last 30 days.